Lipid–drug conjugate for enhancing drug delivery

D Irby, C Du, F Li - Molecular pharmaceutics, 2017 - ACS Publications
Lipid–drug conjugates (LDCs) are drug molecules that have been covalently modified with
lipids. The conjugation of lipids to drug molecules increases lipophilicity and also changes …

Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

M Majidinia, M Mirza‐Aghazadeh‐Attari, M Rahimi… - IUBMB …, 2020 - Wiley Online Library
Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both
conventional and novel chemotherapy agents, is an important barrier in treating …

[HTML][HTML] Paclitaxel nano-delivery systems: a comprehensive review

P Ma, RJ Mumper - Journal of nanomedicine & nanotechnology, 2013 - ncbi.nlm.nih.gov
Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …

Nanodrug delivery in reversing multidrug resistance in cancer cells

S Kapse-Mistry, T Govender, R Srivastava… - Frontiers in …, 2014 - frontiersin.org
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …

Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation

F Ravar, E Saadat, M Gholami… - Journal of controlled …, 2016 - Elsevier
Breast cancer is the leading cause of cancer death in women. Chemotherapy is regarded as
the most essential strategy in inhibiting the proliferation of tumor cells. Paclitaxel is a widely …

Self-assembled lipid–prodrug nanoparticles

P Couvreur, S Lepetre-Mouelhi, E Garbayo… - Nature Reviews …, 2023 - nature.com
Nanomedicines suffer from poor drug loading and uncontrolled 'burst release'after
administration. Combining prodrug strategies with nanostructured carriers can help to …

Nanoparticles for imaging and treatment of metastatic breast cancer

Q Mu, H Wang, M Zhang - Expert opinion on drug delivery, 2017 - Taylor & Francis
Introduction: Metastatic breast cancer is one of the most devastating cancers that have no
cure. Many therapeutic and diagnostic strategies have been extensively studied in the past …

Nanoscale drug delivery systems for cancer therapy using paclitaxel—A review of challenges and latest progressions

G Mustafa, D Hassan, G Ruiz-Pulido… - Journal of Drug Delivery …, 2023 - Elsevier
Paclitaxel (PTX) is an effective anticancer chemical with a broad spectrum that was primarily
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …

Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review

P Ma, RJ Mumper - Nano today, 2013 - Elsevier
Anthracyclines (doxorubicin, daunorubicin, and idarubicin) are very effective
chemotherapeutic drugs to treat many cancers; however, the development of multiple drug …

Lipid prodrug nanocarriers in cancer therapy

S Mura, DT Bui, P Couvreur, J Nicolas - Journal of controlled release, 2015 - Elsevier
Application of nanotechnology in the medical field (ie, nanomedicine) plays an important
role in the development of novel drug delivery methods. Nanoscale drug delivery systems …